Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The EBITDA ratio is 0.36 highlighting the company's operational efficiency. The company reported a substantial revenue of $10,064,700,000.00 reflecting its strong market presence. Additionally, it reported an income before tax of $3,311,400,000.00 showcasing its pre-tax profitability. The cost of revenue for the company is $3,422,400,000.00 showcasing its production and operational expenses. The financial data pertains to the fiscal year 2025. The company offers the da Vinci Surgical System, which facilitates complex surgeries through a minimally invasive approach, along with the Ion endoluminal system that broadens its commercial offerings into diagnostic procedures, enabling minimally invasive biopsies in the lung. Additionally, it provides a suite of stapling, energy, and core instrumentation for its surgical systems, along with progressive learning pathways to support the use of its technology. Intuitive Surgical also offers a range of services to its customers, including support, installation, repair, and maintenance, while its integrated digital capabilities provide unified and connected offerings that streamline hospital performance with program-enhancing insights. The stock is priced at $438.72 positioning it in the higher-end market. It is characterized by a high average trading volume of 1,851,313.00 indicating strong liquidity. With a large market capitalization of $169,741,486,100.00 the company is a dominant player in its field. It is a key player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape. Furthermore, Intuitive Surgical belongs to the Healthcare sector, driving innovation and growth. The focus on delivering enhanced surgical solutions combined with robust financial metrics underscores its prominent role in advancing minimally invasive healthcare solutions, reflecting both market stability and a commitment to quality in patient care.